Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness.

Webinar topics include:

• Industry-leading technologies from Miltenyi Biotec along with a peek into the company’s new CDMO facility dedicated to co-development, tailored application fitment, and scalable cell processing
• Creating process robustness: Equipment, material and reagent considerations, including integrated solutions and process automation and control
• Why it’s important to consider commercial viability, as well as process and technology transfer risk, during pre-clinical development